Ellington Management Group’s DexCom DXCM Stock Holding History

Ellington Management Group’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3,600	Closed	-$242K	–	147
2020 Q1	$242K	Buy	+3,600	New	+$224K	0.06%	382
2018 Q2	–	Sell	-24,400	Closed	-$452K	–	586
2018 Q1	$452K	Buy	+24,400	New	+$361K	0.03%	442
2017 Q4	–	Sell	-46,000	Closed	-$563K	–	645
2017 Q3	$563K	Buy	+46,000	New	+$813K	0.1%	180
2017 Q1	–	Sell	-60,800	Closed	-$907K	–	733
2016 Q4	$907K	Buy	60,800 +28,000	+85%	+$496K	0.14%	85
2016 Q3	$719K	Buy	+32,800	New	+$730K	0.2%	157
2016 Q1	–	Sell	-11,200	Closed	-$229K	–	548
2015 Q4	$229K	Sell	11,200 -8,000	-42%	-$166K	0.08%	397
2015 Q3	$412K	Buy	+19,200	New	+$428K	0.12%	290
2015 Q1	–	Sell	-62,000	Closed	-$853K	–	708
2014 Q4	$853K	Buy	62,000 +26,400	+74%	+$323K	0.28%	64
2014 Q3	$356K	Buy	+35,600	New	+$364K	0.24%	116
2014 Q2	–	Sell	-87,200	Closed	-$902K	–	502
2014 Q1	$902K	Buy	+87,200	New	+$901K	0.26%	75

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Ellington Management Group's DXCM Position: Q2 2020 in Review

Ellington Management Group sold out of DexCom (DXCM) in Q2 2020, closing a stake of 3,600 shares — an estimated $242K sold.

Ellington Management Group first reported a position in DXCM in Q1 2014 and held it in 10 quarters. The position peaked at $907K in Q4 2016. 723 funds tracked by Wall St. Rank hold DXCM as of Q2 2020.

Ellington Management Group reported no remaining DexCom position as of Q2 2020 after selling out during the quarter.
Ellington Management Group sold 3,600 DexCom shares in Q2 2020, an estimated $242K.
Ellington Management Group first reported a position in DexCom in Q1 2014 and held it in 10 quarters.
Ellington Management Group's DexCom position peaked at $907K in Q4 2016.
723 funds tracked by Wall St. Rank held DexCom as of Q2 2020.

Based on Ellington Management Group's 13F filing for Q2 2020, filed 17 Aug 2020.